Engineers Gate Manager LP Kura Oncology, Inc. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $5,311 - $6,962	-303 Reduced 2.45%	12,078 $248,000
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $166,153 - $291,324	12,381 New	12,381 $264,000
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $517,844 - $753,081	53,830 New	53,830 $569,000
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $151,373 - $218,193	-12,850 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $157,027 - $251,474	12,850 New	12,850 $180,000
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $469,831 - $661,786	-30,469 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $635,278 - $910,413	30,469 New	30,469 $635,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $490M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.